BioMedNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Sale of 8 Skyline Medical STREAMWAY(R) Systems to Large University Hospital Organization
Aug 18, 2020
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY(R) System for automated, direct-to-drain medical fluid disposal, has completed the sale of eight systems to a large university hospital organization in Virginia for a new surgical center. According to the update, the organization already has two STREAMWAY systems currently in use. The sale is expected to generate approximately 4,000 annual procedures.
To view the full press release, visit http://ibn.fm/mzHmo
About Predictive Oncology Inc.
Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drives the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions by providing an evidence-based roadmap for therapy. In addition to its proprietary precision-oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Vape prices to rise as new tax takes effect
Vaping is about to becoming more expensive due to a new tax on products.
Mattel Chief Named Co-C.E.O. of Combined Paramount and Warner Bros.
Ynon Kreiz, who will work alongside David Ellison at the merged company, helped turn Barbie into a blockbuster movie.
Trump Dangles Alaska Gas Project as Part of Korean Investment Package
The long-delayed project, which the developer has not yet formally greenlit, would deliver Alaskan gas to Asian markets but take several years to construct.
See how Brazil's ethanol industry is now tied to cattle
For decades, Brazil has been a major ethanol producer, traditionally using sugarcane. More recently, production of ethanol derived from corn has been on the rise and one protein-rich byproduct used for animal feed is in high demand and being exported to several countries worldwide, including China.
Google Wants Hollywood to Stop Being So Afraid of Technology
100 Zeros, a collaboration between Google and Range Media Partners, aims to give the tech giant a foothold in movies, TV and emerging forms of entertainment.
Condé Nast C.E.O. Leaves to Run Mattel
Roger Lynch, who has led the publisher for more than seven years, will become the chief executive of the toy company, he said Wednesday.
How to Listen to Your Favorite Music, Online or Off the Grid
Streaming services can introduce you to a wonderland of nearly unlimited audio, but downloading your digital collection has advantages.
Trump Media’s Merger With Nuclear Fusion Company Moves Closer to Completion
A securities filing laid out the terms of the deal between Truth Social’s parent company and TAE Technologies, which was formally announced in December.
Fed’s Watchdog Finds No Misconduct or Illegal Activity in Costly Renovations
A new report by the Federal Reserve’s independent inspector general concluded that a nearly $2.5 billion construction project was poorly managed but made no referrals to the U.S. attorney general.
E.E.O.C. Sues Harvard for Data on Diversity in Hiring Practices
The Equal Employment Opportunity Commission filed a lawsuit asking a judge to compel the university to provide information on hiring practices that the agency said discriminated against white men.
DeepSeek and Huawei Target a Key Source of Nvidia’s A.I. Dominance
In China’s push for self-reliance in artificial intelligence, DeepSeek and Huawei have teamed up to develop software tools for advanced chips.
Troubles at Situational Awareness Point to Record Stock Market Leverage
A meltdown at Situational Awareness, an A.I.-focused investment firm, is raising tough questions about the Wall Street banks that lent billions to the upstart firm.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.